Harrow Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Harrow Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Harrow Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Harrow Inc. is HROW:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Harrow Inc. has its primary listing on NASDAQ (Small cap). You can trade Harrow Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Harrow Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Harrow Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Harrow Inc. or others.